Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Mario Negri Institute for Pharmacological Research
St. Jude Children's Research Hospital
Northwestern University
Dana-Farber Cancer Institute